Refuse-to-File Letter Issued
New Drug Applications that are incomplete become the subject
of a formal "refuse-to-file" action. In such cases, the
applicant receives a letter detailing the decision and the
deficiencies that form its basis. This decision must be forwarded
within 60 calendar days after the NDA is initially received by
CDER.